Stem Cell Therapy: The Key To Multiple Sclerosis, Details Inside
As the research on stem cell is making medical breakthroughs, it has recently been considered to give hope to multiple sclerosis patients. A new study finding from the National Institutes of Health has revealed that high-dosages of immunosuppressive therapy or HDIT followed by a stem cell transplant can induce remission of a severe form of multiple sclerosis. The study has also further suggested that a one-time stem cell transplants can potentially be more effective as compared to long-term medicinal treatment at treating relapsing-remitting MS.
Stem Cell Therapy For Multiple Sclerosis
According to reports revealed by Newsy, experts have explained that stem cells are basically the type of cells that haven't decided what they want to be when they grow up, which means that they could possibly be developed into different types of cells. Hence, researchers are convinced that they can be used to heal older damaged cells, like those attacked by the immune system as that in multiple sclerosis. In conducting their study, doctors at the National Institute of Allergy and Infectious Diseases (NIAID) which is a part of the National Institutes of Health in the United States have followed 24 people who were noted for having unsuccessful chances with typical MS medications.
The Study's Proposition
Meanwhile, In one of his statements reported by the National Institutes Of Health, NIAID Director Anthony S. Fauci, M.D. has revealed that the trial, dubbed as HALT-MS, suggests that one-time treatment of high-dose immunosuppressive therapy and autologous hematopoietic cell transplant (HDIT/HCT) may be substantially more effective than long-term treatment with the best available medications for people with a certain type of MS. Furthermore, it was found that the experiment treatment also aims to suppress any form of active disease and prevent further disability through the removal of disease-causing cells and resetting the immune system.
Elon Musk Is Working On A Consensual Telepathy; Latest Details Inside
Elon Musk has confirmed that Neuralink is real and that he is serious about the technology. The firm will soon develop a “neural lace” technology that would involve implanting tiny brain electrodes.
Resurrecting Dead People Using Stem Cells Given The Green Light
A biotech company will attempt to resurrect dead people using stem cells starting this year. The Lazarus project was given the green light to reanimate dead brain cells using a groundbreaking procedure..
The Controversial ‘Liberation Therapy’: Is It Good For Multiple Sclerosis?
With the number of advancements that has been intended for Multiple Sclerosis, why is the so-called ‘Liberation Therapy’ found to ineffective? What makes the said therapy to be considered as a failure when it comes to treating the auto-immune disease? Could it mean that it’s now a hopeless case for one of the world’s most dreaded diseases? Here’s what experts have to say
Multiple Sclerosis May Now Be Predicted Through Fatigue And Leg Dysfunction, Experts Say
Considering that the emergence of Multiple Sclerosis is still being considered as mysterious, are there ways to predict if a person is at risk of developing the said auto-immune disease? What’s the truth behind claims that Fatigue and Leg Dysfunction may be used as onset identifiers of the disease? Find out what health experts have to say
Recovery From Multiple Sclerosis Found In The So-Called 'tDCs' Technology, Details Inside
What is 'tDCs'? Considering that Multiple Sclerosis has been one of the world's fast emerging diseases, can the cure be found in this new technology called 'tDCs'? How can a patient recover from the aid auto-immune disease with the help of this technology? Here's what health professionals have to say
Zika Vaccine: Human Trials On Mosquito Saliva Begin
Human testing has begun on a new vaccine that makes humans taste bad to Aedes Aegypti, the Zika-carrying tropical mosquito. The National Institute of Allergies and Infectious Diseases (NIAID) launched last week Phase 1 of clinical trials to test a vaccine intended to protect against mosquito-born viruses.
MORE IN ITECHPOST
'Tokyo Ghoul' Season 3 Delayed By Its Live-Action Movie? Ken Kenaki Returns With Another Identity?
"Tokyo Ghoul" season 3's release is delayed and there are countless speculations as to why it is being pushed back. Reports claim that the show is to give way to "One Punch Man" and "My Hero Acdemia" but new rumors say that it's lack of materials and storyline as well as its live-action movie are causing the delay.